AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) was the recipient of a significant decrease in short interest during the month of August. As of August 14th, there was short interest totaling 458,107 shares, a decrease of 52.7% from the July 30th total of 968,046 shares. Based on an average trading volume of 631,353 shares, the short-interest ratio is currently 0.7 days. Approximately 1.8% of the company’s shares are short sold.
Institutional Trading of AGF U.S. Market Neutral Anti-Beta Fund
A number of large investors have recently modified their holdings of the stock. Crescent Grove Advisors LLC acquired a new stake in AGF U.S. Market Neutral Anti-Beta Fund in the 1st quarter valued at about $6,614,000. Advisory Services Network LLC raised its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 2,091.7% in the fourth quarter. Advisory Services Network LLC now owns 329,604 shares of the company’s stock valued at $4,743,000 after acquiring an additional 314,565 shares in the last quarter. PMV Capital Advisers LLC raised its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 14.0% in the first quarter. PMV Capital Advisers LLC now owns 246,621 shares of the company’s stock valued at $3,443,000 after acquiring an additional 30,234 shares in the last quarter. Worth Asset Management LLC grew its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 20.5% during the 1st quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock worth $425,000 after acquiring an additional 5,190 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 59.4% during the 1st quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock worth $380,000 after purchasing an additional 10,146 shares during the last quarter.
AGF U.S. Market Neutral Anti-Beta Fund Trading Up 1.8%
NYSEARCA BTAL traded up $0.22 during trading hours on Friday, reaching $12.25. The company had a trading volume of 471,391 shares, compared to its average volume of 800,842. The stock has a market capitalization of $308.70 million, a P/E ratio of 17.67 and a beta of -0.64. The stock has a 50-day moving average of $11.84 and a 200 day moving average of $12.58. AGF U.S. Market Neutral Anti-Beta Fund has a 1-year low of $10.86 and a 1-year high of $16.59.
AGF U.S. Market Neutral Anti-Beta Fund Company Profile
The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.
See Also
- Five stocks we like better than AGF U.S. Market Neutral Anti-Beta Fund
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.
